AZoLifeSciences on MSN
Synthetic RNA platform converts viral replication into detectable cellular signals
The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus's own replication ...
Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus' replication
Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including ...
An HIV-derived nucleoside therapy now treats rare genetic diseases by restoring mitochondrial DNA and improving muscle ...
For the first time, scientists have captured how new antiviral drugs halt the herpes virus in real time as it tries to ...
Learn how a newly discovered virus disrupts its host’s nucleus in ways that echo how complex cells may have formed billions ...
Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for ...
The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus's own replication ...
A drug once designed for dengue virus, then quietly abandoned by industry, is suddenly back in the spotlight, and it may be ...
Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...
News-Medical.Net on MSN
Giant amoeba-infecting viruses offer new clues to the origin of eukaryotic life
The origin of life on Earth becomes even more fascinating and complex as we peer into the mysterious world of viruses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results